Table 2 Mouse characteristics for generation of GIST patient-derived xenografts
From: Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor
| Â | Number | Percent (%) |
|---|---|---|
Age at implantation | Â | Â |
  Mean ± standard deviation | 9.1 ± 7.3 weeks |  |
  Range | 5.7 – 30.6 weeks |  |
Gender | Â | Â |
  Male | 8 | 32.0% |
  Female | 17 | 68.0% |
Genotype | Â | Â |
  NOD-scid (NS) | 10 | 40.0% |
  NOD-scid gamma (NSG) | 15 | 60.0% |
Tumor development | Â | Â |
  Yes | 21 | 84.0% |
  No | 4 | 16.0% |
Passages | Â | Â |
  0 (Primary, successes/total) | 11/14 | 85.7% |
  1 (Successes/total) | 5/6 | 83.3% |
  2 (Successes/Total) | 5/5 | 100.0% |
Location of implantation | Â | Â |
  Successful implantations/total | 21/25 | 84.0% |
   Liver (successes/total) | 9/10 | 90.0% |
   Renal capsule (successes/total) | 9/10 | 90.0% |
   Lesser sac (successes/total) | 2/3 | 66.7% |
   Gastric wall (successes/total) | 1/2 | 50.0% |